Rules-Based Medicine, Inc., SEC Filing for Initial Public Offering
December 23, 2009 On December 23, 2009, psychiatric biomarker developer, Rules-Based Medicine, Inc., in Austin, Texas, filed documents with the United States Security and Exchange Commission (SEC) to offer its stock to the public in an Initial Public Offering slated for mid-2010. The company seeks to raise $90 million. It applied to list its stock on the NASDAQ Global Market under the symbol "RULE." Download the Report . . .
